178 related articles for article (PubMed ID: 22313164)
1. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype.
Gardener GJ; Legler TJ; Hyett JA; Liew YW; Flower RL; Hyland CA
Transfusion; 2012 Sep; 52(9):2016-9. PubMed ID: 22313164
[TBL] [Abstract][Full Text] [Related]
2. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive fetal RhD genotyping from maternal blood.
Kolialexi A; Tounta G; Mavrou A
Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
[TBL] [Abstract][Full Text] [Related]
5. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
6. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
[TBL] [Abstract][Full Text] [Related]
8. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
9. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
Daniels G; Finning K; Martin P; Summers J
Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
[TBL] [Abstract][Full Text] [Related]
10. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible].
Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E
Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
Kimura M; Sato C; Hara M; Ishihara O; Ikebuchi K
Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
[TBL] [Abstract][Full Text] [Related]
14. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
Clausen FB; Christiansen M; Steffensen R; Jørgensen S; Nielsen C; Jakobsen MA; Madsen RD; Jensen K; Krog GR; Rieneck K; Sprogøe U; Homburg KM; Grunnet N; Dziegiel MH
Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
[TBL] [Abstract][Full Text] [Related]
17. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
18. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
19. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
Turley E; McGowan EC; Hyland CA; Schoeman EM; Flower RL; Skoll A; Delisle MF; Nelson T; Clarke G; Au N
Transfusion; 2018 Oct; 58(10):2260-2264. PubMed ID: 30222865
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
